Types of Cancer We Treat

AIDS-Related Lymphoma

We draw upon more than 30 years of experience in managing AIDS-related lymphoma, which can develop in people with untreated or advanced HIV. Our specialists use sophisticated diagnostic tools to develop personalized treatment plans for this cancer, which arises in white blood cells called lymphocytes. Treatments can include chemotherapy, targeted drugs, stem cell transplantation, or radiation therapy, combined with antiretroviral therapy. We can also determine whether new therapies offered through a clinical trial may be right for you.

Find a Doctor & Schedule
Diagnosis
Medication
Stem Cell Transplantation
Radiation Therapy

Clinical Trials and Research Studies

Phase 1

A PHASE Ib STUDY EVALUATING THE SAFETY EFFICACY AND PHARMACOKINETICS OF VENETOCLAX IN COMBINATION WITH POLATUZUMAB VEDOTIN PLUS RITUXIMAB (R) AND CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE (CHP) IN PATIENTS WITH UNTREATED BCL-2 IMMUNOHISTOCHEMISTRY (IHC) POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA

Learn More

Phase 1

A PHASE 1 OPEN-LABEL DOSE FINDING STUDY OF CC-95251 A MONOCLONAL ANTIBODY DIRECTED AGAINST SIRPa ALONE AND IN COMBINATION WITH CETUXIMAB OR RITUXIMAB IN SUBJECTS WITH ADVANCED SOLID AND HEMATOLOGIC CANCERS

Learn More

Phase 2

A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine Rituximab High Dose Cytarabine and Acalabrutinib (BR/CR-A) and 3.) Bendamustine Rituximab and Acalabrutinib (BR-A) in Patients = 70 years old with Untreated Mantle Cell Lymphoma

Learn More

Phase 5

A Phase 1-2 First-in-Human Study of CX-2029 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors or Lymphomas.

Learn More
View All Related Clinical Trials (12)